Journal Menu
► ▼ Journal Menu-
- Cancers Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
13 May 2022
National Cancer Research Month | A Message from the Editors-in-Chief of Cancers
As May is National Cancer Research Month, we would like to take this opportunity to thank all the authors who have contributed to Cancers (ISSN: 2072-6694). In particular, we would like to highlight some of the high-quality, high-impact, and innovative research findings published in the journal in the last year, which cover multiple key research areas, including primary prevention, early detection, advanced surgical techniques, and new therapeutic strategies in cancer treatment.
As researchers continue to work tirelessly against COVID-19, several publications have also demonstrated the effectiveness of anti-SARS-CoV-2-antibody vaccination in cancer treatment. Modulating the immune system for cancer immunotherapy remains an actively investigated area. Multiple studies show the effects of immune check inhibitors in cancer treatment, and novel predictive and prognostic biomarkers for multiple cancer types, as well as novel therapeutic approaches for cancer treatment, have also been described. Finally, reviews and research articles have reported the use of spatial omics, an emerging class of high-throughput technologies, to identify novel spatially resolved cancer biomarkers. You can see the list of papers, divided into categories, below:
1. Covid and Clinical Management of Cancer Patients
2. Targeting Immune Check Point Molecules in Cancer Treatment
3. Novel Biomarkers for Cancer Diagnosis and Prognosis
4. Novel Therapeutic Approaches and Clinical Trials Associated with Cancer Treatment
5. Spatial Omics Analyses of Tumor Tissue
We hope that the scientific community will continue to support the journal in working towards disseminating high-impact research findings from researchers and thus improving the survival rates and the quality of life of cancer patients.
Prof. Dr. Samuel C. Mok, Editor-in-Chief of Cancers
Dr. Deepak Nagrath, Associate Editor-in-Chief of Cancers